17 Okt 2014 Jahr - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Zugefügt zum Band der Zeit:

Opioids and the FDA

ByAnastasia

13 Nov 2018

0

0

517

Datum: